首页 > 市场调查报告书 > 医疗设备

医学影像诊断手术用器具

市场调查报告书

商品编码

1347972

全球宫腔镜市场 - 2023-2030

Global Hysteroscopy Market - 2023-2030

出版日期: 2023年09月11日 | 出版商:

DataM Intelligence | 英文 195 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

概述

宫腔镜检查主要用于识别和治疗引起异常子宫出血、月经过多、经期间不规则滴血以及绝经后出血的疾病。该手术允许外科医生使用一种称为宫腔镜的工具观察子宫内部。它通常在医院或门诊手术中心进行，通常在全身麻醉或脊髓麻醉下进行。

宫腔镜检查可以是诊断过程以及治疗过程的一部分。诊断性宫腔镜检查可识别子宫结构异常，也可用于确认超声波等其他检查的结果。手术宫腔镜检查治疗诊断性宫腔镜检查期间发现的异常，子宫内膜去除术是治疗异常子宫出血的常见手术。

此外，技术进步、产品推出和投资增加等重要的增长动力将推动未来市场的增长。 Medtronic Plc.、Olympus Corporation、B. Braun Melsungen AG、Stryker Corporation、Hologic Inc. 等重要参与者都在市场上积极运营。

动力学

增加宫腔镜设备的产品发布

宫腔镜检查是使用宫腔镜进行的，宫腔镜是一根细长的发光管，插入阴道以检查子宫颈和子宫内部。大公司推出的产品有助于推动市场增长，这些有效的研发有助于新诊断和治疗的产品推出，以改善数百万妇科疾病患者的护理。

例如，2023 年 7 月，GenWorks Health 推出了机械宫腔镜组织切除系统，该系统使用简单的机械方法去除宫内组织。它是一种微创系统，已被证明速度更快，还可以完全切除子宫内膜肌瘤和息肉。

此外，UroViu 公司于 2022 年 6 月推出了新型 Hystero-V，这是一款与 UroViu 的 Always Ready 内窥镜平台兼容的一次性宫腔镜。 12-Fr、半刚性 Hystero-V 具有亲水涂层，可实现轻柔插入和卓越的可视化，从而实现高效的宫内检查。因此，由于上述因素，预计市场在预测期内将会提振。

宫腔镜检查投资不断增加

宫腔镜检查是一种微创干预措施，可用于诊断和治疗许多子宫内和宫颈内膜问题。主要公司的主要投资有助于推动市场增长，而来自国家组织和公司的这些有效资金有助于将研究发现转化为妇科疾病的新诊断和治疗方法。

例如，2020 年 10 月，Meditrina 筹集了 1300 万美元，用于将用于治疗宫内病变的 Aveta 系统商业化。 Aveta 系统设计为使用专有的可扩展工作通道宫腔镜以及液体管理和切除系统，在连续流动条件下进行宫腔镜组织碎片切除

宫腔镜检查的缺点将阻碍市场增长

与宫腔镜检查相关的缺点包括宫腔镜检查设备和手术的成本高昂、发展中国家缺乏训练有素的专业人员、与手术相关的并发症和感染的风险、某些地区缺乏对微创手术的认识和不愿意、对批准微创手术的严格规定。宫腔镜设备和农村地区先进医疗设施的使用机会有限。例如，在美国，宫腔镜检查的总费用在 2800 美元到 4800 美元之间。因此，这些因素限制了市场的增长。

Overview

Hysteroscopy is primarily used to identify and treat conditions that cause abnormal uterine bleeding, heavy menstrual bleeding, irregular spotting between periods, and bleeding after menopause. The procedure allows the surgeon to look inside of uterus with a tool called a hysteroscope. It is typically performed in a hospital or outpatient surgical center and is usually done under general or spinal anesthesia.

Hysteroscopy can be a part of the diagnostic process, as well as the treatment process. Diagnostic hysteroscopy identifies structural irregularities in the uterus and also can be used to confirm the results of other tests such as an ultrasound. Operative hysteroscopy treats an abnormality detected during a diagnostic hysteroscopy and endometrial ablation is a common procedure that treats abnormal uterine bleeding.

Furthermore, significant growth drivers such as increasing technological advancements, product launches, and rising investments give rise to future market growth. Significant key players like Medtronic Plc., Olympus Corporation, B. Braun Melsungen AG, Stryker Corporation, Hologic Inc., and others are actively operating in the market.

Dynamics

Increasing Product Launches for Hysteroscopy Devices

Hysteroscopy is done using a hysteroscope which is a thin, lighted tube that is inserted into the vagina to examine the cervix and inside of the uterus. The product launches by major companies help to drive market growth and these effective research and developments help in product launches for new diagnoses, and treatments to improve care for millions of people with gynecological diseases.

For instance, in July 2023, GenWorks Health launched a mechanical hysteroscopic tissue removal system that uses a simple mechanical approach for removing intrauterine tissues. It is a minimally invasive system that has been demonstrated to be quicker and can also completely remove endometrial fibroids and polyps.

Additionally, in June 2022, UroViu Corporation launched the new Hystero-V, a single-use hysteroscope compatible with UroViu's Always Ready endoscopy platform. The 12-Fr, semi-rigid, Hystero-V features a hydrophilic coating enabling gentle insertion and superior visualization for highly effective intrauterine examinations. Hence, due to the above factors, the market is expected to boost over the forecast period.

Rising Investments in Hysteroscopy

Hysteroscopy is a minimally invasive intervention that can be used to diagnose and treat many intrauterine and endocervical problems. The major investments from key companies help to drive market growth and these effective funds from national organizations and companies help to transform research discoveries into new diagnoses and treatments for gynecology diseases.

For instance, in October 2020, Meditrina raised $13 million to commercialize the Aveta system for treating intrauterine pathologies. The Aveta system is designed to use a proprietary expandable working channel hysteroscope, along with a fluid management and resection system, for hysteroscopic tissue chip resection under continuous flow conditions

Drawbacks Associated with Hysteroscopy will Hamper the Market Growth

Drawbacks associated with hysteroscopy include the high cost of hysteroscopy devices and procedures, lack of trained professionals in developing countries, risk of complications and infections associated with the procedure, lack of awareness and reluctance towards minimally invasive procedures in some regions, stringent regulations for approval of hysteroscopy devices and limited access to advanced healthcare facilities in rural areas. For instance, in the United States, the total cost of hysteroscopy varies between $2800 and $4800. Hence, these factors are limiting the market growth.

Segment Analysis

The global hysteroscopy market is segmented based on product, application, end users, and region.

The use of mechanical tissue removal hysteroscopy systems is more frequently implemented as the first-line approach for the treatment of intrauterine pathology. Hysteroscopic tissue removal and retrieval is a procedure performed under local or general anesthesia that allows the doctor to check inside the uterus and remove any polyps or fibroids under direct vision. Tissue removal hysteroscopy systems are expected to hold the largest market share over the period forecast owing to increasing product launches and technical advancements.

For instance, in November 2022, Medtronic plc, launched the TruClear system, a mechanical hysteroscopic tissue removal system used for the safe and effective treatment of intrauterine abnormalities (IUA). TruClear is a next-generation device that provides practitioners with a clear operative field and patients with gentle mechanical resection during the procedure to help efficiently execute a hysteroscopy.

Additionally, in February 2021, VirtaMed launched a hysteroscopy and gynecological laparoscopy mixed tissue removal platform. VirtaMed's hysteroscopy system has been updated to include 16 cases for MyoSure tissue removal, added to over 50 cases in diagnostics, polypectomy, myomectomy, and tissue ablation. Hence, the above factors help to accelerate the market growth.

Geographical Penetration

North America Accounted for Approximately 38.4% of the Market Share in 2022

The global hysteroscopy market is segmented into North America, Europe, Asia Pacific, South America, Middle East, and Africa. North America has maintained a significant proportion of the hysteroscopy market in recent years, and this trend is anticipated to continue throughout the forecast period due to factors such as the rising prevalence and incidence of hysterectomy, and product launches in hysteroscopy devices.

For instance, according to the Centers for Disease Control and Prevention,2022, it states that hysterectomy is the second most common surgical procedure for women and approximately 600,000 hysterectomies are performed in the United States each year. Additionally, From 2012 to 2020, the age-standardized hysterectomy prevalence among adult U.S. women was 17.9%. It steadily increased with each consecutive age group and was highest among women aged more than 80 years (48.8%).

Furthermore, in December 2020, Hologic, Inc. launched its Omni hysteroscope which is an innovative three-in-one modular scope with advanced visualization capabilities designed for both diagnostic and therapeutic hysteroscopic procedures. The Omni scope, which received 510(k) clearance from the U.S. Food and Drug Administration (FDA) is designed to help physicians streamline the process of diagnosing and treating patients

Competitive Landscape

The major global players in the market include: Medtronic Plc., Olympus Corporation, B. Braun Melsungen AG, Stryker Corporation, Hologic Inc., CooperSurgical Inc., XION GmbH, Richard Wolf GmbH, Karl Storz SE & Co., Delmont Imaging among others.

COVID-19 Impact Analysis

The COVID-19 pandemic has had a significant impact on the global hysteroscopy market. The onset of the pandemic in early 2020 led to widespread lockdowns and restrictions, impacting regular check-ups, appointments, device launches, and consultations worldwide. Many hospitals are focused on COVID-19 cases, and this reduces the diagnosis of many patients suffering from various gynecology and obstetrics disorders.

Moreover, the focus of research and development efforts shifted during the pandemic, with a significant emphasis on developing vaccines and treatments for COVID-19. Therefore, owing to the above factors, the hysteroscopy market is expected to be moderately affected over the forecast period.

By Product

Fluid Management Hysteroscopy Systems
Tissue Removal Hysteroscopy Systems
Hand-held Hysteroscopy Systems

Hysteroscopes
- Flexible hysteroscopes
- Rigid hysteroscopes

Contact hysteroscopes
- Hysterosheaths
- Others

By Application

Tubal Sterilization
Hysterectomy
Polypectomy
Myomectomy
Endometrial Ablation
Others

By End Users

Hospitals
Ambulatory Surgical Centers
Others

By Region

North America
- U.S.
- Canada
- Mexico

Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Rest of Europe

South America
- Brazil
- Argentina
- Rest of South America

Asia-Pacific
- China
- India
- Japan
- Australia
- Rest of Asia-Pacific

Middle East and Africa

Key Developments

In October 2022, UroViu Corporation secured a medical equipment ECAT contract for VA DoD Purchasing. The single-use platform ranges from a 12-Fr diagnostic semi-rigid cystoscope and equivalent hysteroscope, a 14-Fr injection cystoscope with an integrated needle for drug delivery, to a flexible, deflectable, and rotatable 16.5-Fr cystoscope.
In October 2021, Hologic, Inc. launched an expanded Omni suite, a comprehensive gynecological surgical offering. The expanded Omni suite aims to optimize diagnostic and operative hysteroscopy in Europe, Africa, and the Middle East (EMEA). The expanded offering includes the Omni 30° hysteroscope, Omni Lok cervical seal, and Omni 5 French seal.

Why Purchase the Report?

To visualize the global hysteroscopy market segmentation based on product, application, end users, and region, as well as understand key commercial assets and players.
Identify commercial opportunities by analyzing trends and co-development.
Excel data sheet with numerous data points of global hysteroscopy market-level with all segments.
PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
Product mapping available as excel consisting of key products of all the major players.

The global hysteroscopy market report would provide approximately 69 tables, 70 figures, and 195 Pages.

Target Audience 2023

Manufacturers/ Buyers
Industry Investors/Investment Bankers
Research Professionals
Emerging Companies

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Product
3.2. Snippet by Application
3.3. Snippet by End Users
3.4. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Increasing Product Launches for Hysteroscopy Devices
  - 4.1.1.2. Rising Investments in Hysteroscopy
- 4.1.2. Restraints
  - 4.1.2.1. Drawbacks Associated with Hysteroscopy
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's 5 Forces Analysis
5.2. Supply Chain Analysis
5.3. Unmet Needs
5.4. Regulatory Analysis
5.5. DMI Opinion

6. COVID-19 Analysis

6.1. Analysis of COVID-19
- 6.1.1. Scenario Before COVID-19
- 6.1.2. Scenario During COVID-19
- 6.1.3. Scenario Post COVID-19
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During the Pandemic
6.5. Manufacturers' Strategic Initiatives
6.6. Conclusion

7. By Product

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 7.1.2. Market Attractiveness Index, By Product
7.2. Fluid Management Hysteroscopy Systems
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Tissue Removal Hysteroscopy Systems
7.4. Hand-held Hysteroscopy Systems
7.5. Hysteroscopes
- 7.5.1. Flexible hysteroscopes
- 7.5.2. Rigid hysteroscopes
- 7.5.3. Contact hysteroscopes
7.6. Hysterosheaths
7.7. Others

8. By Application

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 8.1.2. Market Attractiveness Index, By Application
8.2. Tubal Sterilization
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Hysterectomy
8.4. Polypectomy
8.5. Myomectomy
8.6. Endometrial Ablation
8.7. Others

9. By End Users

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End Users
- 9.1.2. Market Attractiveness Index, By End Users
9.2. Hospitals
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Ambulatory Surgical Centers
9.4. Others

10. By Region

10.1. Introduction
- 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 10.1.2. Market Attractiveness Index, By Region
10.2. North America
- 10.2.1. Introduction
- 10.2.2. Key Region-Specific Dynamics
- 10.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
- 10.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Applications
- 10.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End Users
- 10.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
  - 10.2.6.1. U.S.
  - 10.2.6.2. Canada
  - 10.2.6.3. Mexico
10.3. Europe
- 10.3.1. Introduction
- 10.3.2. Key Region-Specific Dynamics
- 10.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
- 10.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Applications
- 10.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End Users
- 10.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
  - 10.3.6.1. Germany
  - 10.3.6.2. U.K.
  - 10.3.6.3. France
  - 10.3.6.4. Italy
  - 10.3.6.5. Spain
  - 10.3.6.6. Rest of Europe
10.4. South America
- 10.4.1. Introduction
- 10.4.2. Key Region-Specific Dynamics
- 10.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
- 10.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Applications
- 10.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End Users
- 10.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
  - 10.4.6.1. Brazil
  - 10.4.6.2. Argentina
  - 10.4.6.3. Rest of South America
10.5. Asia Pacific
- 10.5.1. Introduction
- 10.5.2. Key Region-Specific Dynamics
- 10.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
- 10.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Applications
- 10.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End Users
- 10.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
  - 10.5.6.1. China
  - 10.5.6.2. India
  - 10.5.6.3. Japan
  - 10.5.6.4. Australia
  - 10.5.6.5. Rest of Asia Pacific
10.6. Middle East and Africa
- 10.6.1. Introduction
- 10.6.2. Key Region-Specific Dynamics
- 10.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
- 10.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Applications
- 10.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End Users

11. Competitive Landscape

11.1. Competitive Scenario
11.2. Product Benchmarking
11.3. Company Share Analysis
11.4. Key Developments and Strategies

12. Company Profiles

12.1. Medtronic Plc.*
- 12.1.1. Company Overview
- 12.1.2. Product Portfolio and Description
- 12.1.3. Financial Overview
- 12.1.4. Key Developments
12.2. Olympus Corporation
12.3. B. Braun Melsungen AG
12.4. Stryker Corporation
12.5. Hologic Inc.
12.6. CooperSurgical Inc.
12.7. XION GmbH
12.8. Richard Wolf GmbH
12.9. Karl Storz SE & Co.
12.10. Delmont Imaging

LIST NOT EXHAUSTIVE